EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

A targeted mass spectrometric assay for quantitative detection of fibrinogen in plasma

Sandip Chavan, Ramesh Bokka, Shilpa Venkataraman, Anikha Bellad, Julie I Tange, Rachel R Leger, Rajiv K Pruthi, Dong Chen, Jansen N Seheult, Akhilesh Pandey

Research and Practice in Thrombosis and Haemostasis · 2026-10 · 10 (7) · 106974

DOI: 10.1016/j.rpth.2026.106974 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Research and Practice in Thrombosis and Haemostasis, 2026-10. Verfasst von Sandip Chavan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Fibrinogen, Tandem Mass Spectrometry, Liquid Chromatography-Mass Spectrometry, Afibrinogenemia. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fibrinogen is a key glycoprotein that plays a central role in clot formation, structure, and stability. Both quantitative fibrinogen deficiency and qualitative abnormalities can lead to bleeding or thrombotic disorders. Accurate quantification of fibrinogen antigen is essential for clinical evaluation; however, current immunoassays and clot-based surrogate methods are prone to interference and may lack traceability to international standards.

Objectives

To develop a targeted mass spectrometry-based assay for accurate quantification of fibrinogen antigen in plasma and to compare its performance with established functional and immunoturbidimetric assays.

Methods

We developed a targeted liquid chromatography-tandem mass spectrometry-based assay using isotope-labeled peptides that accurately measures fibrinogen antigen concentration with high precision (coefficient of variation < 20%) across a broad linear dynamic range of 10.2 to 1307.5 mg/dL, enabling accurate detection of hypofibrinogenemia and hyperfibrinogenemia. Assay performance was evaluated in healthy donors (n = 47) and clinical specimens (n = 31).

Results

Fibrinogen antigen levels in normal donors followed a normal distribution (mean ± SD, 315 ± 42 mg/dL). The targeted assay, employing selected reaction monitoring, correlated strongly with immunoturbidimetry (Pearson's correlation coefficient [r] = .943) and the Clauss and prothrombin time-derived fibrinogen assays (r = .91 and r = .93, respectively). Stratification by clinical category confirmed elevated fibrinogen levels in thrombosis-related disorders, intermediate levels in controls, and low levels in liver disease and critical illness.

Conclusion

The liquid chromatography-tandem mass spectrometry-based assay provides precise, accurate quantification of fibrinogen across a wide clinical range and aligns closely with existing methods while offering analytical specificity. With further clinical validation, it could be used as a diagnostic clinical test.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrinogenTandem Mass SpectrometryLiquid Chromatography-Mass SpectrometryAfibrinogenemiaHumansReproducibility of ResultsFemaleImmunoturbidimetryChromatography, LiquidMaleAdult

Stichwörter der Autor:innen

blood coagulationfibrinogenselected reaction monitoringtandem mass spectrometrythrombosis

Substanzen

Fibrinogen

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Manipal Academy of Higher Education, Manipal, Karnataka, India.
  • Institute of Bioinformatics, International Technology Park, Bangalore, Karnataka, India.
  • Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Chavan, S., Bokka, R., Venkataraman, S., Bellad, A., Tange, J. I., Leger, R. R., Pruthi, R. K., Chen, D., Seheult, J. N., & Pandey, A. (2026). A targeted mass spectrometric assay for quantitative detection of fibrinogen in plasma. Research and Practice in Thrombosis and Haemostasis, 10(7), 106974. https://doi.org/10.1016/j.rpth.2026.106974

Vancouver

Chavan S, Bokka R, Venkataraman S, Bellad A, Tange JI, Leger RR, et al. A targeted mass spectrometric assay for quantitative detection of fibrinogen in plasma. Research and Practice in Thrombosis and Haemostasis. 2026;10(7):106974. doi:10.1016/j.rpth.2026.106974

BibTeX
@article{Chavan2026,
  author = {Chavan, Sandip and Bokka, Ramesh and Venkataraman, Shilpa and Bellad, Anikha and Tange, Julie I and Leger, Rachel R and Pruthi, Rajiv K and Chen, Dong and Seheult, Jansen N and Pandey, Akhilesh},
  title = {A targeted mass spectrometric assay for quantitative detection of fibrinogen in plasma},
  journal = {Research and Practice in Thrombosis and Haemostasis},
  year = {2026},
  volume = {10},
  number = {7},
  pages = {106974},
  doi = {10.1016/j.rpth.2026.106974}
}
Kostenlos starten →